Cite
APA Citation
Awada, A., Eskens, F. A. L. M., Robbrecht, D. G., Lassen, U. N., Sorensen, M., Schellens, J. H. M., de Groot, J. S., Jungels, C., Aftimos, P. G., Fretland, S. O., Thorsson, L., & Guren, T. K. (n.d.). 1172PA first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095516297.0x00003c